1
Oracles of medicine: is preventive medicine worth the investment? Medical costs for treating chronic dieases in Canada Cancers COPD Diabetes Heart Disease Annual cost of treatment ($ billions) 0 3 6 9 12 There are four chronic diseases that account for over 70% of all deaths in Canada, and over 60% of the total direct medical costs to the health care system Preventable 40% Non-preventable 60% 40% of all chronic diseases can be prevented NH 3 O Predictors of diseases can aid in prevention Biomarkers can be used to predict disease Genes Proteins Hormones Test for biomarker Positive for biomarker Preventive medicine $969 mil $22 mil Personalized Medicine CIHR total Research funding by Canadian Institutes of Health Research Biomarkers can also be used to design personalized treatment options, by enhancing potency or specificity of drugs The market for personalized medicine is expected to grow 11% annually to $452 billion by 2015 in the U.S. alone (Source: PriceWaterhouse Coopers) If the development of a disease can be predicted, then the disease can be prevented ©2014, Created by Firhan Malik (fi[email protected]) Source: CAUT Federal Funding review 2013 Source: Mirolla 2004, Cost of Chronic Disease in Canada Source: Mirolla 2004, Cost of Chronic Disease in Canada

Oracles of medicine: is preventive medicine worth the investment?

Embed Size (px)

Citation preview

Page 1: Oracles of medicine: is preventive medicine worth the investment?

Oracles of medicine: is preventive medicine worth the investment?Medical costs for treating chronic dieases in Canada

Cancers

COPD

Diabetes

Heart Disease

Annual cost of treatment ($ billions)0 3 6 9 12

There are four chronic diseases that account for over 70% of all deaths in Canada, and over 60% of the total direct medical costs to the health care system

Preventable 40%

Non-preventable 60%

40% of all chronic diseases can be prevented

NH3

O

Predictors of diseases can aid in

prevention

Biomarkers can be used to predict disease

Genes ProteinsHormones

Test for biomarker

Positive for biomarker

Preventive medicine

$969 mil$22 mil

Personalized Medicine

CIHR total

Research funding by Canadian Institutes of Health Research

Biomarkers can also be used to design personalized treatment options, by enhancing potency or specificity of drugs

The market for personalized medicine is expected to grow 11% annually to $452 billion by 2015 in the U.S. alone (Source:

PriceWaterhouse Coopers)

If the development of a disease can be predicted, then the disease can be prevented

©2014, Created by Firhan Malik ([email protected])

Source: CAUT Federal Funding review 2013

Source: Mirolla 2004, Cost of Chronic Disease in Canada

Source: Mirolla 2004, Cost of Chronic Disease in Canada